Habermann Jens K, Roblick Uwe J, Upender Madhvi, Ried Thomas, Auer Gert
Laboratory for Surgical Research, Department of Surgery, University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.
Adv Exp Med Biol. 2006;587:161-77. doi: 10.1007/978-1-4020-5133-3_15.
Biomedical research has advanced rapidly in recent years with the sequencing of the human genome and the availability of technologies such as global gene and protein expression profiling using different chip platforms. However, this progress has not yet been transferred to the bedside. While detection of cancer at early stages is critical for curative treatment interventions, efficient diagnostic and therapeutic markers for the majority of malignancies still seem to be lacking. Comprehensive tumor profiling has therefore become a field of intensive research aiming at identifying biomarkers relevant for improved diagnostics and therapeutics. This chapter will demonstrate a genomic and proteomic approach while focusing on tumor profiling during colorectal cancer development.
近年来,随着人类基因组测序以及诸如使用不同芯片平台进行全基因组和蛋白质表达谱分析等技术的出现,生物医学研究取得了迅速进展。然而,这一进展尚未转化为临床应用。虽然早期癌症检测对于根治性治疗干预至关重要,但大多数恶性肿瘤仍然缺乏有效的诊断和治疗标志物。因此,全面的肿瘤谱分析已成为一个深入研究的领域,旨在识别与改善诊断和治疗相关的生物标志物。本章将展示一种基因组和蛋白质组学方法,同时重点关注结直肠癌发生过程中的肿瘤谱分析。